Anakinra for systemic juvenile idiopathic arthritis

被引：0
|
作者：
不详
机构：
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2011年 / 96卷 / 05期
关键词：
D O I：
10.1136/adc.2011.300076
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [31] Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
    Record, Jessica L.
    Beukelman, Timothy
    Cron, Randy Q.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (01) : 179 - 181
  • [32] TREATMENT OF REFRACTORY MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH HIGH DOSE ANAKINRA.
    Kwong, J.
    Peng, T.
    Mohiuddin, A.
    Weiss, P. F.
    Cron, R. Q.
    Chefitz, D.
    Craig, V.
    Weissmann, D.
    Andujar-DeLaCruz, J.
    Moorthy, L. N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A71 - A71
  • [33] LONG-TERM SAFETY OF ANAKINRA IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS FROM THE PHARMACHILD REGISTRY
    Giancane, G.
    Papa, R.
    Vastert, S.
    Bagnasco, F.
    Swart, J. F.
    Quartier, P.
    Hofer, M.
    Anton, J.
    Kamphuis, S.
    Sanner, H.
    Glerup, M.
    De Benedetti, F.
    Tsitsami, E.
    Remesal, A.
    Ruzafa, E. Moreno
    De Inocencio, J.
    Myrup, C.
    Pallotti, C.
    Kone-Paut, I.
    Franck-Larsson, K.
    Malmstrom, H.
    Cederholm, S.
    Pistorio, A.
    Wulffraat, N.
    Ruperto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 98 - 99
  • [34] Neutrophils Gene expression profile in systemic Juvenile Idiopathic Arthritis (sJIA) patients treated successfully with Anakinra
    Omoyinmi, Ebun
    Hamaoui, Raja
    Radziszewska, Anna
    Bryant, Annette
    Zheng, Dongling
    Banerjee, Priya
    Woo, Patricia
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 437 - 437
  • [35] Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
    C. M. Hedrich
    N. Bruck
    B. Fiebig
    M. Gahr
    Rheumatology International, 2012, 32 : 3525 - 3530
  • [36] Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
    Hedrich, C. M.
    Bruck, N.
    Fiebig, B.
    Gahr, M.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (11) : 3525 - 3530
  • [37] Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry
    Giancane, Gabriella
    Papa, Riccardo
    Vastert, Sebastiaan
    Bagnasco, Francesca
    Swart, Joost F.
    Quartier, Pierre
    Anton, Jordi
    Kamphuis, Sylvia
    Sanner, Helga
    Glerup, Mia
    De Benedetti, Fabrizio
    Tsitsami, Elena
    Remesal, Agustin
    Moreno, Estefania
    De Inocencio, Jaime
    Myrup, Charlotte
    Pallotti, Chiara
    Kone-Paut, Isabelle
    Franck-Larsson, Karin
    Malmstrom, Hakan
    Cederholm, Susanna
    Pistorio, Angela
    Wulffraat, Nico
    Ruperto, Nicolino
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (04) : 398 - 407
  • [38] Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
    Kearsley-Fleet, Lianne
    Beresford, Michael W.
    Davies, Rebecca
    De Cock, Diederik
    Baildam, Eileen
    Foster, Helen E.
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2019, 58 (01) : 94 - 102
  • [39] Treatment of systemic juvenile idiopathic arthritis
    Claas H. Hinze
    Dirk Foell
    Christoph Kessel
    Nature Reviews Rheumatology, 2023, 19 : 778 - 789
  • [40] Treatment of systemic juvenile idiopathic arthritis
    Hinze, Claas H.
    Foell, Dirk
    Kessel, Christoph
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (12) : 778 - 789
12345